Scott M. Mcfarlane Sells 12,000 Shares of Avalara Inc (AVLR) Stock

Avalara Inc (NYSE:AVLR) insider Scott M. Mcfarlane sold 12,000 shares of the firm’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $53.03, for a total value of $636,360.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Avalara stock opened at $54.67 on Friday. The stock has a market cap of $3.81 billion and a P/E ratio of -50.62. Avalara Inc has a 52 week low of $28.09 and a 52 week high of $59.40.

Avalara (NYSE:AVLR) last posted its quarterly earnings data on Tuesday, February 12th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.01. The company had revenue of $76.90 million for the quarter, compared to analysts’ expectations of $71.24 million. The company’s revenue was up 32.6% on a year-over-year basis. As a group, analysts expect that Avalara Inc will post -0.86 earnings per share for the current year.

A number of research analysts have recently weighed in on the company. Zacks Investment Research upgraded Avalara from a “sell” rating to a “hold” rating in a research report on Monday, December 3rd. Goldman Sachs Group restated a “buy” rating and issued a $50.00 price target on shares of Avalara in a research report on Friday, February 1st. JMP Securities raised their price target on Avalara from $40.00 to $49.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 13th. JPMorgan Chase & Co. raised their price target on Avalara from $38.00 to $64.00 and gave the company a “positive” rating in a research report on Wednesday, February 13th. Finally, KeyCorp restated a “buy” rating on shares of Avalara in a research report on Monday, January 7th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $49.00.

Institutional investors have recently bought and sold shares of the stock. Legal & General Group Plc purchased a new stake in Avalara during the 3rd quarter worth about $46,000. Oppenheimer Asset Management Inc. purchased a new stake in Avalara during the 4th quarter worth about $71,000. Metropolitan Life Insurance Co. NY increased its position in Avalara by 209.2% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 3,222 shares of the company’s stock worth $100,000 after purchasing an additional 2,180 shares in the last quarter. JPMorgan Chase & Co. increased its position in Avalara by 127.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,121 shares of the company’s stock worth $109,000 after purchasing an additional 1,751 shares in the last quarter. Finally, Convergence Investment Partners LLC purchased a new stake in Avalara during the 4th quarter worth about $126,000. Hedge funds and other institutional investors own 73.75% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first published by Stock Observer and is the property of of Stock Observer. If you are viewing this news story on another website, it was stolen and reposted in violation of United States & international trademark & copyright law. The original version of this news story can be accessed at https://www.thestockobserver.com/2019/03/15/scott-m-mcfarlane-sells-12000-shares-of-avalara-inc-avlr-stock.html.

About Avalara

Avalara, Inc provides transaction tax compliance cloud-based solutions worldwide. It offers a suite of compliance solutions that enable businesses to address the complexity of transaction tax compliance; process transactions in real time; produce detailed records of transaction tax determinations; and reduce errors, audit exposure, and total transaction tax compliance costs.

See Also: Fiduciary

Insider Buying and Selling by Quarter for Avalara (NYSE:AVLR)

Receive News & Ratings for Avalara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalara and related companies with MarketBeat.com's FREE daily email newsletter.